4.7 Review

Purinergic receptors in cognitive disturbances

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Extracellular ATP: A powerful inflammatory mediator in the central nervous system

Francesco Di Virgilio et al.

Summary: Nucleotides, especially extracellular ATP (eATP), play a crucial role in inter-species extracellular signaling. Different organisms have evolved sensors with varying affinity and selectivity for eATP, resulting in a highly flexible signaling system. In mammalian evolution, the control of intracellular ATP and eATP homeostasis is closely linked to that of Ca2+. Specific plasma membrane receptors, known as P2 receptors (P2Rs), sense eATP with various degrees of affinity and selectivity, adding to the plasticity of the system. The central nervous system (CNS) is a privileged site for purinergic signaling, with all brain cell types expressing P2Rs. Evidence suggests that eATP not only participates in synaptic transmission but also plays a crucial homeostatic role in brain cell responses. Modulating eATP concentration in the CNS may hold promise for the treatment of neuroinflammation.

NEUROPHARMACOLOGY (2023)

Article Neurosciences

Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum

Sergi Ferre et al.

Summary: Adenosine plays a significant role in modulating striatal neurotransmission, which is mediated by A1 and A2A receptors. The modulation involves different components of the striatal microcircuit and the formation of heteromers. These heteromers have unique properties and provide fine-tune modulation of striatal glutamate release. Targeting these adenosine receptor heteromers may be important for drug development in neuropsychiatric disorders.

NEUROPHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy

Marta Anglada-Huguet et al.

Summary: Blocking adenosine A(1) receptors with rolofylline can reverse tau pathology and synaptic decay. The efficacy of this treatment on more aggressive forms of tauopathy remains to be explored.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

Accumbal adenosine A2A receptor inactivation biases for large and costly rewards in the effort- but not delay-based decision making

Xiaoting Sun et al.

Summary: This study identifies the important role of A2AR in the nucleus accumbens in the control of effort-based decision making and suggests that pharmacological targeting of A2ARs could be an effective strategy for treating the aberrant effort-based decision making in neuropsychiatric disorders.

NEUROPHARMACOLOGY (2023)

Article Neurosciences

Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease

Deidiane Elisa Ribeiro et al.

Summary: About 10 million new cases of dementia occur globally each year, with up to 70% attributed to Alzheimer's disease (AD). AD patients often experience non-cognitive symptoms known as behavioral and psychological symptoms of dementia (BPSDs), including sleep disorders and mood alterations such as depression and apathy. BPSDs have a significant impact on AD patients, caregivers, public health systems, and the economy. Understanding the role of purinergic signaling, particularly the A1, A2A, and P2X7 receptors, in AD may provide new therapeutic approaches for the disease and related conditions.

NEUROPHARMACOLOGY (2023)

Article Multidisciplinary Sciences

Lateral septum adenosine A2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula

Muran Wang et al.

Summary: Major depressive disorder is a significant burden globally, but current antidepressant medications have limitations. The authors discovered a population of neurons in the lateral septum that mediate depressive symptoms by connecting with the lateral habenula and dorsomedial hypothalamus. Activation of A2A receptors in the lateral septum leads to decreased activity of surrounding neurons and triggers depressive phenotypes. The upregulation of A2A receptors in the lateral septum is identified as a critical regulator of stress-induced depressive behaviors, suggesting the potential of A2A receptor antagonists as antidepressants.

NATURE COMMUNICATIONS (2023)

Article Clinical Neurology

The Improvement of Sepsis-Associated Encephalopathy by P2X7R Inhibitor through Inhibiting the Omi/HtrA2 Apoptotic Signaling Pathway

Kaifang Wang et al.

Summary: The study examines the influence of P2X7R on cognitive function in sepsis-associated encephalopathy (SAE) and its underlying molecular mechanism. The results show that P2X7R inhibitors improve the survival rate of mice, alleviate cognitive dysfunction caused by LPS stimulation, and reduce brain cell apoptosis. In addition, the inhibition of P2X7R also reduces the production and accumulation of reactive oxygen species (ROS) and inhibits the apoptosis signaling pathway associated with mitochondrial serine protease Omi/HtrA2.

BEHAVIOURAL NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor

Beatriz Gil et al.

Summary: Epilepsy is a common chronic disease with difficult treatment, and P2X7R antagonists may serve as a novel therapeutic strategy for epilepsy and its associated comorbidities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Clinical Neurology

Prenatal Poly I:C Challenge Affects Behaviors and Neurotransmission via Elevated Neuroinflammation Responses in Female Juvenile Rats

Yueqing Su et al.

Summary: Exposure to Poly I:C during pregnancy can lead to increased anxiety-like and depression-like behaviors, as well as neurotransmitter changes, in female adolescent offspring. However, cognitive function appears to improve in the novel object recognition memory test in the Poly I:C group.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

Article Neurosciences

Entrainment of Astrocytic and Neuronal Ca2+ Population Dynamics During Information Processing of Working Memory in Mice

Zhu Lin et al.

Summary: Recent studies have shown that astrocytes in the hippocampus exhibit calcium dynamics regulated by sensory inputs and reward delivery, with synchronized but phase-differing dynamics compared to neurons. Additionally, robust synchronization of astrocytic calcium dynamics at the population level was observed among the hippocampus, medial prefrontal cortex, and striatum. The inter-locked, bidirectional communication between astrocytes and neurons may play a role in modulating information processing in working memory.

NEUROSCIENCE BULLETIN (2022)

Review Neurosciences

A Possible Causal Involvement of Neuroinflammatory, Purinergic P2X7 Receptors in Psychiatric Disorders

Ying Zhang et al.

Summary: P2X7 receptors are primarily found in peripheral macrophages and microglial cells, and their activation leads to the release of proinflammatory cytokines, contributing to neurodegenerative and psychiatric diseases. Antagonists of P2X7 receptors could be potential therapeutics for psychiatric diseases.

CURRENT NEUROPHARMACOLOGY (2022)

Article Cell Biology

G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodeling in microglia

Hariharakrishnan Chidambaram et al.

Summary: In Alzheimer's disease, Tau protein misfolds and forms aggregates in neuronal cells. Microglial cells can phagocytose Tau protein by interacting with the P2Y12 receptor. The repeat-domain of Tau interacts with the microglial P2Y12 receptor, leading to internalization and degradation of Tau protein.

EUROPEAN JOURNAL OF CELL BIOLOGY (2022)

Article Neurosciences

Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease

Jie-Ming Jian et al.

Summary: This study investigated the alteration of antibodies against P2RY2 in AD patients and found that these antibodies were reduced in AD patients. Levels of certain antibodies were associated with cognitive performances and biomarkers, suggesting a potential role of these antibodies in the pathogenesis of AD.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Review Biochemistry & Molecular Biology

Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease

Stefania Merighi et al.

Summary: The A(2A) adenosine receptor plays an important role in Alzheimer's disease and can be counteracted by antagonists to relieve clinical symptoms. Research has also found that the pharmacokinetics and ability to pass the blood-brain barrier are crucial in the discovery of new drugs for CNS disorders.

MOLECULES (2022)

Article Neurosciences

Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease

Boyd Kenkhuis et al.

Summary: This study analyzed the expression patterns of microglia markers, Iba1, TMEM119, and P2RY12, in Alzheimer's disease patients. The results revealed a significant loss of TMEM119 expression and an increase in P2RY12 expression in Alzheimer patients. No morphological features were associated with the loss or gain of these markers or phenotypes.

NEUROBIOLOGY OF DISEASE (2022)

Review Pharmacology & Pharmacy

International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update

Adriaan P. IJzerman et al.

Summary: This review provides an update on the nomenclature and classification of adenosine receptors, with a focus on emerging developments in protein structure, diversity, and modulation by small molecules. It also explores novel concepts such as target binding kinetics and biased signaling, as well as discusses the clinical trials and pharmacology of adenosine receptor ligands.

PHARMACOLOGICAL REVIEWS (2022)

Article Environmental Sciences

HMGB1-NLRP3-P2X7R pathway participates in PM2.5-induced hippocampal neuron impairment by regulating microglia activation

Chong Liu et al.

Summary: This study reveals the mechanism of hippocampal neuron impairment induced by neuroinflammation caused by PM2.5 exposure, and identifies the role of the HMGB1-NLRP3-P2X7R pathway in the activation of microglia.

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2022)

Article Neurosciences

Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: Integration of the glutamate/GABA-glutamine cycle

Jens Andersen et al.

Summary: Astrocytes play a significant role in the development of Alzheimer's disease. They collaborate closely with neurons through neurotransmitter recycling, which is essential for neurotransmission. The metabolic changes in astrocytes during Alzheimer's disease can have a profound impact on neurotransmitter recycling and deprive neurons of metabolic support, leading to synaptic dysfunction and neurodegeneration.

PROGRESS IN NEUROBIOLOGY (2022)

Article Neurosciences

α-Synuclein Selectively Impairs Motor Sequence Learning and Value Sensitivity: Reversal by the Adenosine A2A Receptor Antagonists

Yan He et al.

Summary: This study investigates the behavioral mechanism of alpha-Syn in Parkinson's disease (PD) and suggests a novel therapeutic strategy to improve sequence-learning deficit by using adenosine A2A receptor antagonists.

CEREBRAL CORTEX (2022)

Article Biochemistry & Molecular Biology

Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice

Eleonore Bertin et al.

Summary: Increased surface density of neuronal P2X4 contributes to synaptic deficits, alterations in anxiety and memory functions, consistent with the implication of P2X4 in neuropsychiatric and neurodegenerative disorders. These conditional P2X4mCherryIN knock-in mice provide a new approach to explore the cell-specific roles of P2X4 in various physiological and pathological contexts.

MOLECULAR PSYCHIATRY (2021)

Review Pharmacology & Pharmacy

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

Peter Illes et al.

Summary: P2X receptors are cationic channels consisting of seven different subunits, with researchers having determined their structure and function. In addition, primitive ligand-gated counterparts related to P2X receptors have been cloned, and various selective antagonists have been discovered.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

The potential of the P2X7 receptor as a therapeutic target in a sub-chronic PCP-induced rodent model of schizophrenia

Hui Huang et al.

Summary: By studying the role of the P2X7 receptor in a mouse model, it was found that antagonizing the P2X7 receptor significantly improved cognitive impairment induced by PCP. The results suggest that the P2X7 receptor plays an important role in cognition in schizophrenic-like mice.

JOURNAL OF CHEMICAL NEUROANATOMY (2021)

Article Biochemistry & Molecular Biology

Loss of P2Y12 Has Behavioral Effects in the Adult Mouse

Rebecca L. Lowery et al.

Summary: While microglia play a critical role in synaptic plasticity, their utilization of molecular signals varies temporally and regionally. The purinergic receptor P2Y12 is not universally required for synaptic plasticity, but its loss can lead to functional defects in recognition, social memory, and anxiety-like behaviors in adult mice. This highlights the complexity of microglial involvement in different forms of plasticity across developmental stages and brain regions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Neurosciences

P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy

Kevin Carvalho et al.

Summary: The purinergic receptor P2X7 plays a crucial role in Alzheimer's disease and Tauopathies, with deletion of P2X7 having significant effects on inflammatory mediators and memory function in Tau pathology. P2X7 inhibitors may be ideal drugs for treating these neurodegenerative diseases.

PROGRESS IN NEUROBIOLOGY (2021)

Article Cell Biology

Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis

Rashmi Das et al.

Summary: Research has shown that extracellular Tau oligomers directly interact with microglial P2Y12R and induce expression of this purinergic receptor in microglia. ATP, as an inducer of P2Y12R, facilitates the localization of this receptor during accelerated microglial migration. This interaction between Tau oligomers and microglial P2Y12R facilitates signal transduction for directional chemotaxis and receptor-mediated phagocytosis.

TRAFFIC (2021)

Article Psychiatry

Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice

Antonella Ferrante et al.

Summary: In fragile X syndrome, the functional synergistic coupling between A(2A) and mGlu5 receptors may be increased. Chronic A(2A)R blockade partially restores some phenotypes of Fmr1 KO mice.

TRANSLATIONAL PSYCHIATRY (2021)

Review Neurosciences

Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer's Disease

Catia R. Lopes et al.

Summary: Astrocytes play a crucial role in Alzheimer's disease by regulating synaptic plasticity and cognitive functions through bidirectional communication with neurons. Changes in astrocytes at early and later stages of AD impact their function, with potential involvement of adenosine receptors like A(2A)R. Understanding the role of A(2A)R in astrocyte function could lead to novel therapeutic strategies against AD, given the increased levels of these receptors in the AD brain.

FRONTIERS IN NEUROSCIENCE (2021)

Editorial Material Pharmacology & Pharmacy

Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases

Talita Glaser et al.

FRONTIERS IN PHARMACOLOGY (2021)

Review Immunology

Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy

Tobias Engel et al.

Summary: The treatment of epilepsy remains challenging, with chronic inflammation playing a crucial role in its pathogenesis. Identifying and targeting mechanisms that regulate inflammation may be a promising strategy for future epilepsy treatment. ATP-gated receptors are considered novel drug targets for epilepsy, showing potential for anticonvulsant and antiepileptic effects.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Article Clinical Neurology

Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor

Jun Maeda et al.

Summary: Recent studies have shown a significant down-regulation of microglial P2Y12 receptor levels in neurodegenerative diseases, particularly associated with tau pathology. This finding may serve as a sensitive index for neuroinflammatory responses in Alzheimer's disease-related neurodegenerative processes.

BRAIN COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Age-related shift in LTD is dependent on neuronal adenosine A2Areceptors interplay with mGluR5 and NMDA receptors

Mariana Temido-Ferreira et al.

MOLECULAR PSYCHIATRY (2020)

Article Pharmacology & Pharmacy

Update of P2Y Receptor Pharmacology: IUPHAR Review:27

Kenneth A. Jacobson et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Clinical Neurology

Late-onset Huntington's disease with 40-42 CAG expansion

Elisa Capiluppi et al.

NEUROLOGICAL SCIENCES (2020)

Article Clinical Neurology

Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression

Daniele Guilhermano Machado et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)

Review Neurosciences

Pathological ATPergic Signaling in Major Depression and Bipolar Disorder

Peter Illes et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Review Biochemistry & Molecular Biology

The emerging role of ?-synuclein truncation in aggregation and disease

Zachary A. Sorrentino et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Clinical Neurology

Medical, Surgical, and Genetic Treatment of Huntington Disease

Christine M. Stahl et al.

NEUROLOGIC CLINICS (2020)

Review Neurosciences

The Role of P2X7 Receptor in Alzheimer's Disease

Linda Francistiova et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Article Pharmacology & Pharmacy

Purinergic signaling orchestrating neuron-glia communication

Paula Agostinho et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Neurosciences

P2X7 Receptor Upregulation in Huntington's Disease Brains

Ivana Olla et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Article Psychiatry

Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia

Cassidy L. Moody et al.

SCHIZOPHRENIA BULLETIN (2020)

Article Biochemistry & Molecular Biology

New role of P2X7 receptor in an Alzheimer's disease mouse model

Elodie Martin et al.

MOLECULAR PSYCHIATRY (2019)

Review Pharmacology & Pharmacy

The P2X7 receptor: a new therapeutic target in Alzheimer's disease

Peter Illes et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Article Neurosciences

Accumbal Adenosine A2A Receptors Enhance Cognitive Flexibility by Facilitating Strategy Shifting

Jianhong Zhou et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

The role of adenosine receptors in mood and anxiety disorders

Dietrich van Calker et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Review Pharmacology & Pharmacy

Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders

Maria Rosaria Domenici et al.

PHARMACOLOGICAL RESEARCH (2019)

Review Neurosciences

Ion Channels and Receptors as Determinants of Microglial Function

Pablo Izquierdo et al.

TRENDS IN NEUROSCIENCES (2019)

Review Clinical Neurology

Cognitive impairment in depression: recent advances and novel treatments

Giulia Perini et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)

Review Biochemistry & Molecular Biology

Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment

Leide Caroline dos Santos Picanco et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Review Clinical Neurology

Huntington's disease: a clinical review

P. McColgan et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Immunology

P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model

Nicole Reichenbach et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Physiology

PHARMACOLOGY OF ADENOSINE RECEPTORS: THE STATE OF THE ART

Pier Andrea Borea et al.

PHYSIOLOGICAL REVIEWS (2018)

Review Physiology

PHYSIOLOGY OF ASTROGLIA

Alexei Verkhratsky et al.

PHYSIOLOGICAL REVIEWS (2018)

Review Chemistry, Multidisciplinary

P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?

Chris N. J. Young et al.

FRONTIERS IN CHEMISTRY (2018)

Review Neurosciences

ALZHEIMER DISEASE Rodent models for Alzheimer disease

Juergen Goetz et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Review Neurosciences

Bidirectional Microglia-Neuron Communication in Health and Disease

Zsuzsanna Szepesi et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Review Medicine, General & Internal

Depression

Gin S. Malhi et al.

LANCET (2018)

Review Immunology

The P2X7 Receptor in Infection and Inflammation

Francesco Di Virgilio et al.

IMMUNITY (2017)

Review Biochemistry & Molecular Biology

Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration

Jocelyn Stockwell et al.

MOLECULES (2017)

Article Multidisciplinary Sciences

On the permeation of large organic cations through the pore of ATP-gated P2X receptors

Mahboubi Harkat et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain

David Elmenhorst et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Neurosciences

The ATP-Gated P2X7 Recept or As a Target for the Treatment of Drug-Resistant Epilepsy

Edward Beamer et al.

FRONTIERS IN NEUROSCIENCE (2017)

Review Neurosciences

Chronic psychosocial stressors in adulthood: Studies in mice, rats and tree shrews

Christopher R. Pryce et al.

NEUROBIOLOGY OF STRESS (2017)

Correction Biochemistry & Molecular Biology

A(2A) adenosine receptor deletion is protective in a mouse model of Tauopathy (vol 21, pg 149, 2016)

C. Laurent et al.

MOLECULAR PSYCHIATRY (2016)

Article Neurosciences

Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly

Michael Malek-Ahmadi et al.

JOURNAL OF ALZHEIMERS DISEASE (2016)

Article Clinical Neurology

Clinical Considerations of Obstructive Sleep Apnea with Little REM Sleep

Dae Lim Koo et al.

JOURNAL OF CLINICAL NEUROLOGY (2016)

Article Multidisciplinary Sciences

Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors

Silvia Viana da Silva et al.

NATURE COMMUNICATIONS (2016)

Review Respiratory System

Sleep Apnea-Hypopnea Syndrome and Type 2 Diabetes. A Reciprocal Relationship?

Elisabet Martinez Ceron et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2015)

Article Biochemistry & Molecular Biology

Physiopathological Roles of P2X Receptors in the Central Nervous System

G. Burnstock

CURRENT MEDICINAL CHEMISTRY (2015)

Article Neurosciences

Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory

Anna G. Orr et al.

NATURE NEUROSCIENCE (2015)

Article Neurosciences

Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides

Timo Jan Oberstein et al.

NEUROBIOLOGY OF DISEASE (2015)

Review Respiratory System

Sleep Apnea-Hypopnea Syndrome and Type 2 Diabetes. A Reciprocal Relationship?

Elisabet Martinez Ceron et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2015)

Review Pharmacology & Pharmacy

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

Christiane Reitz et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Vanessa Flaten et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2014)

Article Psychiatry

Cognitive Dysfunction in Major Depressive Disorder: Effects on Psychosocial Functioning and Implications for Treatment

Raymond W. Lam et al.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)

Review Physiology

Purinergic signalling: from discovery to current developments

Geoffrey Burnstock

EXPERIMENTAL PHYSIOLOGY (2014)

Article Geriatrics & Gerontology

Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology

Cyril Laurent et al.

NEUROBIOLOGY OF AGING (2014)

Article Biochemistry & Molecular Biology

Contribution of P2X4 Receptors to Ethanol Intake in Male C57BL/6 Mice

Letisha R. Wyatt et al.

NEUROCHEMICAL RESEARCH (2014)

Review Neurosciences

The challenges of clinical trials in fragile X syndrome

Sebastien Jacquemont et al.

PSYCHOPHARMACOLOGY (2014)

Review Pharmacology & Pharmacy

P2X7 receptor: an emerging target in central nervous system diseases

Beata Sperlagh et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2014)

Review Neurosciences

Connexons and pannexons: newcomers in neurophysiology

Giselle Cheung et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2014)

Review Neurosciences

What causes Alzheimer's disease?

Richard A. Armstrong

FOLIA NEUROPATHOLOGICA (2013)

Article Clinical Neurology

Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin

Marco Bortolato et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

P2Y4 Receptor-Mediated Pinocytosis Contributes to Amyloid Beta-Induced Self-Uptake by Microglia

Hui-quan Li et al.

MOLECULAR AND CELLULAR BIOLOGY (2013)

Review Neurosciences

Emerging role for astroglial networks in information processing: from synapse to behavior

Ulrike Pannasch et al.

TRENDS IN NEUROSCIENCES (2013)

Article Behavioral Sciences

Modulation of the extinction of two different fear-motivated tasks in three distinct brain areas

Natalia Gindri Fiorenza et al.

BEHAVIOURAL BRAIN RESEARCH (2012)

Review Biochemistry & Molecular Biology

Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future

Geoffrey Burnstock

BIOESSAYS (2012)

Review Neurosciences

Connexin-based intercellular communication and astrocyte heterogeneity

Martin Theis et al.

BRAIN RESEARCH (2012)

Article Neurosciences

Selective cognitive impairment in the YAC128 Huntington's disease mouse

Simon P. Brooks et al.

BRAIN RESEARCH BULLETIN (2012)

Article Biochemistry & Molecular Biology

Ezrin/Radixin/Moesin Are Required for the Purinergic P2X7 Receptor (P2X7R)-dependent Processing of the Amyloid Precursor Protein

Amaria Darmellah et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Pharmacology & Pharmacy

Roles of Dopamine and Inflammation-Related Molecules in Behavioral Alterations Caused by Repeated Stress

Tomoyuki Furuyashiki

JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)

Article Neurosciences

Adenosine hypothesis of schizophrenia - Opportunities for pharmacotherapy

Detlev Boison et al.

NEUROPHARMACOLOGY (2012)

Review Neurosciences

Reversal learning as a measure of impulsive and compulsive behavior in addictions

Alicia Izquierdo et al.

PSYCHOPHARMACOLOGY (2012)

Review Biochemistry & Molecular Biology

Neuroprotective roles of the P2Y2 receptor

Gary A. Weisman et al.

PURINERGIC SIGNALLING (2012)

Article Medicine, General & Internal

Coffee, Caffeine, and Risk of Depression Among Women

Michel Lucas et al.

ARCHIVES OF INTERNAL MEDICINE (2011)

Review Biochemistry & Molecular Biology

Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration

Catarina V. Gomes et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)

Article Pharmacology & Pharmacy

P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers

L. S. Antonio et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Article Chemistry, Medicinal

Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain

Fiona E. Parkinson et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)

Review Chemistry, Medicinal

Adenosine and ATP Receptors in the Brain

Geoffrey Burnstock et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

The Purinergic Receptor P2X7 Triggers α-Secretase-dependent Processing of the Amyloid Precursor Protein

Cecile Delarasse et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Review Biochemistry & Molecular Biology

C terminus of the P2X7 receptor: treasure hunting

Helio Miranda Costa-Junior et al.

PURINERGIC SIGNALLING (2011)

Review Cell Biology

ATP: A ubiquitous gliotransmitter integrating neuron-glial networks

Arthur M. Butt

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)

Article Neurosciences

P2Y1 receptors inhibit long-term depression in the prefrontal cortex

Segundo J. Guzman et al.

NEUROPHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Homotrimeric complexes are the dominant assembly state of native P2X7 subunits

Annette Nicke

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Review Biochemistry & Molecular Biology

Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies

Reinaldo Naoto Takahashi et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Article Pharmacology & Pharmacy

Evidence for functional P2X4/P2X7 heteromeric receptors

Chang Guo et al.

MOLECULAR PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Go it alone no more - P2X7 joins the society of heteromeric ATP-gated receptor channels

George R. Dubyak

MOLECULAR PHARMACOLOGY (2007)

Review Neurosciences

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

Uwe-Karsten Hanisch et al.

NATURE NEUROSCIENCE (2007)

Review Pharmacology & Pharmacy

Targeting the dopamine D2 receptor in schizophrenia

Philip Seeman

EXPERT OPINION ON THERAPEUTIC TARGETS (2006)

Review Pharmacology & Pharmacy

Purinergic P2 receptors as targets for novel analgesics

Geoffrey Burnstock

PHARMACOLOGY & THERAPEUTICS (2006)

Article Multidisciplinary Sciences

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

A Nimmerjahn et al.

SCIENCE (2005)

Article Biochemistry & Molecular Biology

P2X7 mediates superoxide production in primary microglia and is up-regulated in a Transgenic mouse model of Alzheimer's disease

LK Parvathenani et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Review Physiology

Molecular physiology of P2X receptors

RA North

PHYSIOLOGICAL REVIEWS (2002)

Article Neurosciences

P2X receptor trafficking in neurons is subunit specific

LK Bobanovic et al.

JOURNAL OF NEUROSCIENCE (2002)

Article Multidisciplinary Sciences

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor

B Johansson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Neurosciences

Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats

MS Gevaerd et al.

BRAIN RESEARCH BULLETIN (2001)

Review Pharmacology & Pharmacy

Molecular pharmacology of P2Y-receptors

I von Kügelgen et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)

Review Pharmacology & Pharmacy

Neuronal P2X receptors:: localisation and functional properties

W Nörenberg et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)

Article Pharmacology & Pharmacy

Brilliant Blue G selectively blocks ATP-gated rat P2X7 receptors

LH Jiang et al.

MOLECULAR PHARMACOLOGY (2000)